Abilify® Settlement Amounts, Compensation and Victim Payouts
Abilify® is an antipsychotic drug with a list of devastating side effects, that manufacturers failed to properly warn the public of in a timely manner.
The U.S. Food and Drug Administration (FDA) initially approved Abilify® in 2002 as a treatment for schizophrenia.
The first Abilify® related settlement was for $515,000,000 and was finalized in 2007 between Bristol-Myers Squibb and the U.S. Justice Department.
Multiple Abilify® Lawsuits are currently being filed against Bristol-Myers Squibb for failing to disclose the compulsive behaviors as a possible side effect of Abilify®, and settlement amounts for Abilify® lawsuits are likely to be substantial.
Compulsive and often addictive behaviors caused by Abilify® include:
- Overeating and weight gain
- Pathological gambling
- Excessive shopping